Decreased cAMP response element-mediated transcription - An early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis

被引:114
作者
Sugars, KL [1 ]
Brown, R [1 ]
Cook, LJ [1 ]
Swartz, J [1 ]
Rubinsztein, DC [1 ]
机构
[1] Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2XY, England
关键词
D O I
10.1074/jbc.M310226200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is one of nine neurodegenerative diseases caused by an expanded polyglutamine (polyQ) tract within the disease protein. To characterize pathways induced early in HD, we have developed stable inducible PC12 cell lines expressing wild-type or mutant forms of huntingtin exon 1 fragments or the full-length huntingtin protein. Three cAMP response element-binding protein (CREB)-binding protein-dependent transcriptional pathways, regulated by cAMP response element (CRE), retinoic acid response element, and nuclear factor kappaB, show abnormalities in our exon 1 cell model. Of these, the CRE pathway shows the earliest disruption and is significantly down-regulated as early as 12 h following mutant htt transgene induction. This pathway is also the only one of the three that is similarly perturbed in our full-length HD model, where it is also down-regulated at an early time point, compatible with observations in HD brains. Reduced CRE-dependent transcription may contribute to polyQ disease pathogenesis because overexpression of transcriptionally active CREB, but not an inactive form of the protein, is able to protect against polyQ-induced cell death and reduce aggregation.
引用
收藏
页码:4988 / 4999
页数:12
相关论文
共 49 条
[1]   Nuclear hormone receptors and gene expression [J].
Aranda, A ;
Pascual, A .
PHYSIOLOGICAL REVIEWS, 2001, 81 (03) :1269-1304
[2]   Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study [J].
Augood, SJ ;
Faull, RLM ;
Love, DR ;
Emson, PC .
NEUROSCIENCE, 1996, 72 (04) :1023-1036
[3]   Recent advances in understanding NF-κB regulation [J].
Boone, DL ;
Lee, EG ;
Libby, S ;
Gibson, PJ ;
Chien, M ;
Chan, F ;
Madonia, M ;
Burkett, PR ;
Ma, A .
INFLAMMATORY BOWEL DISEASES, 2002, 8 (03) :201-212
[4]   Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation [J].
Carmichael, J ;
Sugars, KL ;
Bao, YP ;
Rubinsztein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :33791-33798
[5]   Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis [J].
Chai, YH ;
Shao, JQ ;
Miller, VM ;
Williams, A ;
Paulson, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) :9310-9315
[6]  
Chai YH, 1999, J NEUROSCI, V19, P10338
[7]   Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease [J].
Chan, EYW ;
Luthi-Carter, R ;
Strand, A ;
Solano, SM ;
Hanson, SA ;
DeJohn, MM ;
Kooperberg, C ;
Chase, KO ;
DiFiglia, M ;
Young, AB ;
Leavitt, BR ;
Cha, JHJ ;
Aronin, N ;
Hayden, MR ;
Olson, JM .
HUMAN MOLECULAR GENETICS, 2002, 11 (17) :1939-1951
[8]   Functional analysis of the Huntington's disease (HD) gene promoter [J].
Coles, R ;
Caswell, R ;
Rubinsztein, DC .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :791-800
[9]   Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 [J].
Cummings, CJ ;
Mancini, MA ;
Antalffy, B ;
DeFranco, DB ;
Orr, HT ;
Zoghbi, HY .
NATURE GENETICS, 1998, 19 (02) :148-154
[10]   CORTICOTROPIN-RELEASING HORMONE (CRH) IS DECREASED IN THE BASAL GANGLIA IN HUNTINGTONS-DISEASE [J].
DESOUZA, EB ;
WHITEHOUSE, PJ ;
FOLSTEIN, SE ;
PRICE, DL ;
VALE, WW .
BRAIN RESEARCH, 1987, 437 (02) :355-359